Early in the pandemic, various reports27,28,29,30 suggested that ARBs and ACE inhibitors might be associated with increased susceptibility to SARS-CoV-2 infection and worse outcomes for COVID-19 cases. The gene discussed is ACE; the disease is COVID-19.